Gossamer Bio, Inc. (GOSS)
10.71
-0.22
(-2.01%)
USD |
NASDAQ |
Oct 02, 16:00
10.72
+0.01
(+0.09%)
After-Hours: 20:00
Gossamer Bio Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -275.2% |
| December 31, 2025 | -342.3% |
| September 30, 2025 | -362.7% |
| June 30, 2025 | -333.1% |
| Date | Value |
|---|---|
| March 31, 2025 | -370.5% |
| December 31, 2024 | -352.2% |
| September 30, 2024 | -324.9% |
| June 30, 2024 | 51.37% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| United Therapeutics Corp. | 42.51% |
| Arbutus Biopharma Corp. | -507.2% |
| Kura Oncology, Inc. | -327.3% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -75.64% |
| Return on Invested Capital | -181.5% |
| Gross Profit Margin (Quarterly) | 97.27% |
| Operating Margin (Quarterly) | -282.2% |
| Return on Net Operating Assets | -958.1% |